NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 31,798 Shares

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 31,798 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34. Following the completion of the sale, the chief executive officer now owns 146,539 shares of the company’s stock, valued at approximately $1,074,130.87. The trade was a 17.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

George Lawrence Mikan III also recently made the following trade(s):

  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Stock Down 1.2 %

Shares of NEUE stock opened at $7.33 on Friday. The stock has a market cap of $60.73 million, a price-to-earnings ratio of -0.14 and a beta of 0.57. NeueHealth, Inc. has a fifty-two week low of $3.79 and a fifty-two week high of $16.59. The firm’s 50 day moving average price is $5.60 and its two-hundred day moving average price is $5.42.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in NEUE. Renaissance Technologies LLC acquired a new position in shares of NeueHealth during the second quarter worth $312,000. NEA Management Company LLC acquired a new position in shares of NeueHealth during the second quarter worth $14,834,000. Deer Management Co. LLC acquired a new position in shares of NeueHealth during the second quarter worth $5,436,000. Finally, Partners Group Holding AG acquired a new position in shares of NeueHealth during the third quarter worth $463,000. 63.88% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reduced their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

Get Our Latest Research Report on NeueHealth

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Stories

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.